Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie: = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Würzburg
August 2022
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | erschienen 2023 |
| Beschreibung: | 61 Blätter Diagramme |
| DOI: | 10.25972/OPUS-30612 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048993658 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 230609s2022 gw |||| m||| 00||| ger d | ||
| 015 | |a 23,O05 |2 dnb | ||
| 035 | |a (OCoLC)1385286670 | ||
| 035 | |a (DE-599)BVBBV048993658 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a ger | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-384 |a DE-473 |a DE-703 |a DE-1051 |a DE-824 |a DE-29 |a DE-12 |a DE-91 |a DE-19 |a DE-1049 |a DE-92 |a DE-739 |a DE-898 |a DE-355 |a DE-706 |a DE-20 |a DE-1102 |a DE-860 |a DE-2174 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Heider, Melanie |d 1995- |e Verfasser |0 (DE-588)1292500506 |4 aut | |
| 245 | 1 | 0 | |a Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie |b = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |c vorgelegt von Melanie Heider aus Langenselbold |
| 246 | 1 | 1 | |a Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| 264 | 1 | |a Würzburg |c August 2022 | |
| 300 | |a 61 Blätter |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a erschienen 2023 | ||
| 502 | |b Dissertation |c Julius-Maximilians-Universität Würzburg |d 2023 | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 650 | 0 | 7 | |8 4\p |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Rezidiv |0 (DE-588)4130100-6 |2 gnd |
| 650 | 0 | 7 | |8 6\p |a Metastase |0 (DE-588)4125915-4 |2 gnd |
| 650 | 0 | 7 | |8 7\p |a Patient |0 (DE-588)4044903-8 |2 gnd |
| 653 | |a Androgendeprivation | ||
| 653 | |a Prostataspezifisches Membranantigen | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |o urn:nbn:de:bvb:20-opus-306123 |o doi:10.25972/OPUS-30612 |
| 856 | 4 | 1 | |u https://doi.org/10.25972/OPUS-30612 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034256955 | ||
| 883 | 0 | |8 1\p |a emakn |c 0,96734 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
| 883 | 0 | |8 2\p |a emasg |c 0,93682 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emasg | |
| 883 | 1 | |8 3\p |a npi |d 20230410 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
| 883 | 0 | |8 4\p |a emagnd |c 0,61681 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
| 883 | 0 | |8 5\p |a emagnd |c 0,10319 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
| 883 | 0 | |8 6\p |a emagnd |c 0,05277 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
| 883 | 0 | |8 7\p |a emagnd |c 0,05014 |d 20230411 |q DE-101 |u https://d-nb.info/provenance/plan#emagnd | |
Datensatz im Suchindex
| _version_ | 1804185251518349312 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Heider, Melanie 1995- |
| author_GND | (DE-588)1292500506 |
| author_facet | Heider, Melanie 1995- |
| author_role | aut |
| author_sort | Heider, Melanie 1995- |
| author_variant | m h mh |
| building | Verbundindex |
| bvnumber | BV048993658 |
| collection | ebook |
| ctrlnum | (OCoLC)1385286670 (DE-599)BVBBV048993658 |
| doi_str_mv | 10.25972/OPUS-30612 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02772nam a2200541zc 4500</leader><controlfield tag="001">BV048993658</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230609s2022 gw |||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,O05</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1385286670</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048993658</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Heider, Melanie</subfield><subfield code="d">1995-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1292500506</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie</subfield><subfield code="b">= Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy</subfield><subfield code="c">vorgelegt von Melanie Heider aus Langenselbold</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Würzburg</subfield><subfield code="c">August 2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">61 Blätter</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">erschienen 2023</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Julius-Maximilians-Universität Würzburg</subfield><subfield code="d">2023</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Rezidiv</subfield><subfield code="0">(DE-588)4130100-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">6\p</subfield><subfield code="a">Metastase</subfield><subfield code="0">(DE-588)4125915-4</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">7\p</subfield><subfield code="a">Patient</subfield><subfield code="0">(DE-588)4044903-8</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Androgendeprivation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Prostataspezifisches Membranantigen</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="o">urn:nbn:de:bvb:20-opus-306123</subfield><subfield code="o">doi:10.25972/OPUS-30612</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.25972/OPUS-30612</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034256955</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,96734</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">0,93682</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20230410</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,61681</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,10319</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">6\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,05277</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">7\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,05014</subfield><subfield code="d">20230411</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV048993658 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T22:08:00Z |
| indexdate | 2024-07-10T09:52:16Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034256955 |
| oclc_num | 1385286670 |
| open_access_boolean | 1 |
| owner | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| owner_facet | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| physical | 61 Blätter Diagramme |
| psigel | ebook |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| record_format | marc |
| spelling | Heider, Melanie 1995- Verfasser (DE-588)1292500506 aut Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy vorgelegt von Melanie Heider aus Langenselbold Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy Würzburg August 2022 61 Blätter Diagramme txt rdacontent n rdamedia nc rdacarrier erschienen 2023 Dissertation Julius-Maximilians-Universität Würzburg 2023 Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager 4\p Prostatakrebs (DE-588)4047511-6 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Metastase (DE-588)4125915-4 gnd 7\p Patient (DE-588)4044903-8 gnd Androgendeprivation Prostataspezifisches Membranantigen (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe urn:nbn:de:bvb:20-opus-306123 doi:10.25972/OPUS-30612 https://doi.org/10.25972/OPUS-30612 Resolving-System kostenfrei Volltext 1\p emakn 0,96734 20230411 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 0,93682 20230411 DE-101 https://d-nb.info/provenance/plan#emasg 3\p npi 20230410 DE-101 https://d-nb.info/provenance/plan#npi 4\p emagnd 0,61681 20230411 DE-101 https://d-nb.info/provenance/plan#emagnd 5\p emagnd 0,10319 20230411 DE-101 https://d-nb.info/provenance/plan#emagnd 6\p emagnd 0,05277 20230411 DE-101 https://d-nb.info/provenance/plan#emagnd 7\p emagnd 0,05014 20230411 DE-101 https://d-nb.info/provenance/plan#emagnd |
| spellingShingle | Heider, Melanie 1995- Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy 4\p Prostatakrebs (DE-588)4047511-6 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Metastase (DE-588)4125915-4 gnd 7\p Patient (DE-588)4044903-8 gnd |
| subject_GND | (DE-588)4047511-6 (DE-588)4130100-6 (DE-588)4125915-4 (DE-588)4044903-8 (DE-588)4113937-9 |
| title | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| title_alt | Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| title_auth | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| title_exact_search | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| title_exact_search_txtP | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| title_full | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy vorgelegt von Melanie Heider aus Langenselbold |
| title_fullStr | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy vorgelegt von Melanie Heider aus Langenselbold |
| title_full_unstemmed | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy vorgelegt von Melanie Heider aus Langenselbold |
| title_short | Detektionsrate der 68 Ga-PSMA-PET/CT bei Patienten mit Rezidiv eines Prostatakarzinoms und Androgendeprivationstherapie |
| title_sort | detektionsrate der 68 ga psma pet ct bei patienten mit rezidiv eines prostatakarzinoms und androgendeprivationstherapie detection rate of 68 ga psma ligand pet ct in patients with recurrent prostate cancer and androgen deprivation therapy |
| title_sub | = Detection Rate of 68 Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy |
| topic | 4\p Prostatakrebs (DE-588)4047511-6 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Metastase (DE-588)4125915-4 gnd 7\p Patient (DE-588)4044903-8 gnd |
| topic_facet | Prostatakrebs Rezidiv Metastase Patient Hochschulschrift |
| url | https://doi.org/10.25972/OPUS-30612 |
| work_keys_str_mv | AT heidermelanie detektionsrateder68gapsmapetctbeipatientenmitrezidiveinesprostatakarzinomsundandrogendeprivationstherapiedetectionrateof68gapsmaligandpetctinpatientswithrecurrentprostatecancerandandrogendeprivationtherapy AT heidermelanie detectionrateof68gapsmaligandpetctinpatientswithrecurrentprostatecancerandandrogendeprivationtherapy |